A new diagnostic development in MRI screening for breast cancer

• Conditions: 10006291; breast cancer; mamma carcinoma

• Registration Number: NL-OMON33969
• Lead Sponsor: niversitair Medisch Centrum Groningen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 30

Inclusion Criteria

solid breast lesion >= 1cm
BIRADS classification 3 or 4 on the mammogram.
Patients are >= 18 years

Exclusion Criteria

history of breast cancer
breast hematoma
protheses
claustrophobia
non-MR compatible implants
disorder of kidney function

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>To compare the specificity of the multiple-voxel MR spectroscopy with the<br /><br>standard MRI and<br /><br>as second main aim a reduction of the number of false-positive diagnostic<br /><br>outcomes.<br /><br>Sensitivity, specificity, positive predictive value, negative predictive value<br /><br>and 95% CI will be calculated. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>No applicable</p><br>